A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma
DOI:
10.1007/s13691-025-00749-y
Publication Date:
2025-01-23T13:11:14Z
AUTHORS (12)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (13)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....